Delivery Order 36F79721D0166-36C26024F0240
Award Date
2/20/24
Potential Completion Date
5/20/24
Potential Value
$30K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Biocryst Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Earth City, MO 63045, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product ORLADEYO (berotralstat) to the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 20 (VISN 20). The prime contractor is Biocryst Pharmaceuticals Inc., a biotechnology company that specializes in developing small molecule drugs for rare diseases. The contract is a delivery order under Biocryst's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, which has a ceiling...
This federal contract award is for the delivery of BEROTRALSTAT HCL 150MG CAP (trade name ORLADEYO 150MG CAP) to the U.S. Department of Veterans Affairs (VA). The $379,348.93 contract was awarded to Biocryst Pharmaceuticals Inc., a biotechnology company that specializes in developing small molecule drugs for rare diseases. This is a Firm Fixed Price delivery order placed under Biocryst's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has an...
This federal contract award was made by the Veterans Integrated Service Network 20 (VISN 20), a civilian agency, to Biocryst Pharmaceuticals Inc., a biotechnology company specializing in rare disease pharmaceuticals. The $379,939.32 firm fixed-price delivery order contract is for the supply of BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO), a medication used to treat hereditary angioedema. The contract has an ultimate completion date of September 30, 2025 and was awarded on October 1, 2024. The...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Biocryst Pharmaceuticals Inc. The contract is a definitive, cost-plus-fixed-fee contract with a ceiling value of $11,911,993.55 and an ultimate completion date of May 31, 2021. The contract does not have a set-aside designation. Biocryst Pharmaceuticals is a biotechnology company that specializes in developing small molecule drugs for rare diseases. The contract is for...
Biocryst Pharmaceuticals Inc. has received a $29,649.88 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply berotralstat and berotralstat hydrochloride capsules. The delivery order was awarded against Biocryst's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), and carries a completion date of May 16, 2024. No set-aside designation was used for this award. Biocryst will perform under...
This is a federal contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a Civilian agency, to Biocryst Pharmaceuticals Inc., a for-profit pharmaceutical company based in Durham, North Carolina. The contract, valued at $22,500,000.00, is for the delivery of drugs and biologicals, with a period of performance ending on November 2, 2011. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Biocryst Pharmaceuticals Inc....
Biocryst Pharmaceuticals, Inc. was awarded a $56,670.76 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The contract calls for the delivery of berotralstat to Roseburg, Oregon with a period of performance concluding on January 19, 2024. No set-aside designation was applied to this award issued against GSA Schedule 61-IB for pharmaceutical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $113,440.80 delivery order to Biocryst Pharmaceuticals, Inc. under the firm fixed price Pharmaceuticals and Drugs Federal Supply Schedule contract. This order is for the delivery of BEROTRALSTAT HCL 150MG CAP,ORAL BULK to the place of performance in Durham, North Carolina by May 31, 2023. The contract was awarded on June 1, 2022 and has no set-aside designation. Biocryst...
This is a $204,984,698.95 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Biocryst Pharmaceuticals Inc. for the advance development of a new antiviral agent for influenza under the Pandemic Influenza Preparedness program. The contract does not have a set-aside designation, indicating Biocryst competed for the award in the open market. Biocryst is a biotechnology...
This federal contract award is for the delivery of OXBRYTA 500 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,250.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company...